Tempest Therapeutics, Inc. (TPST) Financials
TPST Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 9.6 million | 10.7 million |
| March 31, 2026 | 10.7 million | 9.9 million |
| Dec. 31, 2025 | 16.9 million | 10.3 million |
| Sept. 30, 2025 | 17.1 million | 10.8 million |
TPST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.8 million | -117000 |
| March 31, 2026 | -7.6 million | 226000 |
| Dec. 31, 2025 | -3.6 million | 576000 |
| Sept. 30, 2025 | -6.8 million | 61000 |
TPST Net Income
No data available :(
TPST Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 779000 | 6.3 million | - |
| March 31, 2026 | 1.8 million | 6.6 million | 1.2 million |
| Dec. 31, 2025 | 7.7 million | 6.9 million | 1.2 million |
| Sept. 30, 2025 | 7.5 million | - | 8.4 million |
TPST Shares Outstanding
TPST Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 1.8 million | 3.4 million | - |
| March 31, 2026 | - | 114000 | 5.4 million | - |
| Dec. 31, 2025 | - | 538000 | 3.5 million | - |
| Sept. 30, 2025 | - | 570000 | 3.0 million | - |
TPST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 22.2 million |
| Dec. 31, 2025 | - | 65000 |
| Sept. 30, 2025 | - | 66000 |
TPST
Price: $1.07
52 week price:
Earnings Per Share: -5.70 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 5600
Market Capitalization: 16.2 million